Initial trials suggest that this peptide – a dual agonist of incretin and a related hormone receptors – may provide a significant improvement in weight reduction programs . Beyond existing treatments , the peptide seems to affect appetite and calorie burn through separate pathways . While additional copyrightination is required , current data